Form 4 Tracker
KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS

41 insider filings · Latest: Sep 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 15, 2026Apr 16 9:03 PMBrian Daniel WebsterDirector, President and Chief Executive Officer
Sale
15,000$20.04$300.7K349,786(D)

View →

Apr 15, 2026Apr 15 8:18 PMWebster Brian Daniel
Proposed Sale
15,000$20.04$300.7K—

View →

Mar 26, 2026Mar 30 10:06 PMRaymond W CohenDirector
Purchase
10,000$19.98$199.8K50,903(D)

View →

Mar 17, 2026Mar 19 8:10 PMBrian Daniel WebsterDirector, President and Chief Executive Officer
Sale
15,000$20.27$304.1K364,786(D)

View →

Mar 17, 2026Mar 17 10:17 PMWebster Brian Daniel
Proposed Sale
15,000$20.27$304.1K—

View →

Feb 17, 2026Feb 19 9:35 PMBrian Daniel WebsterDirector, President and Chief Executive Officer
Sale
15,000$25.60$384.0K379,786(D)

View →

Feb 17, 2026Feb 17 9:05 PMWebster Brian Daniel
Proposed Sale
15,000$25.60$384.0K—

View →

Jan 15, 2026Jan 20 11:00 AMBrian Daniel WebsterDirector, President and Chief Executive Officer
Sale
15,000$22.80$342.0K394,786(D)

View →

Jan 15, 2026Jan 15 9:20 PMWebster Brian Daniel
Proposed Sale
15,000$22.80$342.0K—

View →

Dec 29, 2025Dec 31 9:16 PMTraci S UmbergerDirector, General Counsel and Chief Administrative Officer
Sale
10,500$26.69$280.2K136,633(D)

View →

Dec 29, 2025Dec 31 9:14 PMBrian Daniel WebsterDirector, President and Chief Executive Officer
Sale
15,000$26.59$398.8K409,786(D)

View →

Dec 29, 2025Dec 29 9:36 PMUmberger Traci S
Proposed Sale
10,500$26.69$280.2K—

View →

Dec 29, 2025Dec 29 9:35 PMWebster Brian Daniel
Proposed Sale
15,000$26.59$398.8K—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives

No transactions found.